Thymosin Alpha-1: Immune Modulation Research and Thymic Function

What is Thymosin Alpha-1?

Thymosin Alpha-1 (also called thymalfasin) is a 28-amino-acid peptide naturally produced by the thymus gland — the primary lymphoid organ where T cells mature. The compound is N-terminally acetylated, with the acetylation essential for biological activity. The molecular weight is 3108.4 Da. Within the broader immune-modulation research compound class, Thymosin Alpha-1 is one of the most extensively characterised research tools. Researchers can access Thymosin Alpha-1 research peptide at Advanced Peptide Science at 99%+ HPLC-verified purity.

Research Background

Thymosin Alpha-1 was first isolated from the thymic fraction 5 extract in the 1970s — a major research finding linking thymic biology to circulating immune-modulating peptide signals. The compound was subsequently characterised, sequenced, and synthesised, enabling research applications across the immune modulation, antiviral immune response, and dendritic cell biology research fields. Within the Longevity & Immune Support category at Advanced Peptide Science, Thymosin Alpha-1 is the dedicated thymic-immune-modulation research compound, complementing the thymic bioregulator Vilon within the Khavinson bioregulator framework.

Mechanism of Action

Mechanism research investigates Thymosin Alpha-1 activation of Toll-like receptors (notably TLR9 and TLR2) on dendritic cells. TLR engagement drives dendritic cell maturation — including upregulation of MHC class II, CD80/CD86 co-stimulatory molecules, and IL-12 production. The matured dendritic cells subsequently present antigens to T cells with stronger costimulation and Th1-skewing cytokine context, supporting cellular immune response polarisation. The combined effects make Thymosin Alpha-1 a research tool for investigating TLR-pathway-dependent immune signalling and adaptive immune response polarisation.

Key Research Findings

TLR9 and TLR2 Receptor Pathway Activation

TLR9 is canonically activated by unmethylated CpG DNA motifs (such as those found in bacterial DNA); TLR2 is canonically activated by bacterial lipopeptides. Thymosin Alpha-1 binding to these receptors expands the research-tool framework for TLR pathway investigation — providing a peptide-based TLR agonist alongside conventional DNA-based and lipid-based TLR agonist tool compounds.

Dendritic Cell Maturation

Dendritic cells are professional antigen-presenting cells; their maturation state determines the strength of T-cell priming. Thymosin Alpha-1 research investigates the magnitude and kinetics of dendritic cell maturation responses, including measurement of MHC class II surface expression, CD80/CD86 upregulation, and IL-12 secretion — standard markers of mature dendritic cell phenotype.

Th1 Immune Response Polarisation

The combined effects of TLR pathway activation and dendritic cell maturation polarise downstream T-cell responses toward the Th1 cellular immunity phenotype (vs Th2 humoral or Th17 inflammatory). Th1 polarisation is research-relevant for antiviral and intracellular pathogen immune response research.

Research Applications

Thymosin Alpha-1 research applications span TLR9/TLR2 pathway pharmacology, dendritic cell biology research, T-cell proliferation and polarisation studies, antiviral immune response preclinical model investigation, and comparative immune-modulation peptide research. Within the Longevity & Immune Support category, the compound complements the thymic bioregulator Vilon for thymic-function research, the cathelicidin LL-37 for innate immunity research, and the Khavinson bioregulators including Epitalon and Pinealon.

Research Specifications

Molecular Weight	3108.4 Da
Sequence Length	28 amino acids
Modification	N-terminal acetylation (essential for biological activity)
Alternative Name	Thymalfasin
Primary Receptors	Toll-like receptors TLR9 and TLR2
Format	Lyophilized powder in sterile vial
Purity	≥ 99% (HPLC verified)
Storage	-20 °C, protect from light

Frequently Asked Questions

What is the significance of N-terminal acetylation?

The N-terminal acetylation of Thymosin Alpha-1 is essential for biological activity — non-acetylated forms are inactive in receptor-binding research. This makes the acetylated form a research-tool example of post-translational-modification-dependent peptide pharmacology.

Why is Thymosin Alpha-1 also called thymalfasin?

Thymalfasin is the international nonproprietary name (INN) for the synthetic Thymosin Alpha-1. The two terms refer to the same compound.

How does Thymosin Alpha-1 differ from other immune-modulating peptides?

Within the Advanced Peptide Science catalogue, Thymosin Alpha-1 is the principal Toll-like receptor agonist research peptide. Compare against Vilon (Khavinson bioregulator framework) and LL-37 (cathelicidin antimicrobial peptide with immunomodulatory effects).

Is Thymosin Alpha-1 approved for human use?

Advanced Peptide Science supplies Thymosin Alpha-1 exclusively for in vitro and in vivo scientific research. Not for human consumption. Research use only.

---

For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.